Advisory Board

Chairman of Urology, Hospital Professor of Urology

NYU School of Medicine

Dr. Katz established and serves as the Program Director of Urology Residency Program at NYU Long Island School of Medicine and is an attending physician at Winthrop Urology, a progressive urology practice with offices in Garden City, Long Island and the Upper East Side of Manhattan. Prior to joining Winthrop, he was a Professor of Urology at Columbia University Hospital College of Physicians and Surgeons and was the Director of the Center for Holistic Urology, a center which he established in 1998 performing basic research and clinical trials to investigate the role of natural therapies within urology.

Dr. Katz is also recognized as an expert in the field of prostate cryosurgery. In the early 1990s, he began using cryosurgery to treat and cure prostate cancers. His pioneer work in advancing the technology helped Medicare approve this therapy for treating radiation-recurrent tumors. Dr. Katz has trained over 100 Urologists internationally to perform cryosurgery in their hospitals. Dr. Katz has published more than 150 scientific articles in peer-reviewed journals, and has written five chapters for Urologic textbooks. He is currently the host of “Katz’s Corner”, a men’s health radio program aired every Sunday morning at 7 a.m. on WABC Radio.

Professor & Director of Women’s Health Integrative Medicine Research Program

UTHealth McGovern Medical School

Dr. Judith A. Smith is a Professor and Director of the WHIM Research Program in the Department of Obstetrics, Gynecology and Reproductive Sciences at UTHealth McGovern Medical School and an oncology clinical pharmacy specialist at the UTHealth-Memorial Hermann Cancer Center and at Children’s Memorial Hermann Hospital.  She received a Bachelor of Science in Pharmacy and Doctor of Pharmacy from Union University Albany College of Pharmacy.  She completed residency in Pharmacy Practice and Oncology Pharmacy Practice at National Institutes of Health (NIH) followed by a fellowship in Clinical Pharmacology at UT M.D. Anderson Cancer Center (UTMDACC). Previously she was a Faculty member in the Department of Gynecologic Oncology at UTMDACC and provided oncology clinical pharmacy services in their Gynecologic Oncology Center for over 15 years.   Dr. Smith is an active member of many national and international professional organizations.  She is currently serving as the inaugural chair of the NRG Oncology Pharmacy Subcommittee that she was instrumental in making it come to fruition.   She is Board Certified in Oncology Pharmacy and Certified Professional in Healthcare Quality.

Integrative Medicine Specialist and Medical Director of Integrative Medicine Service

Memorial Sloan Kettering Cancer Center

Dr. Gary E. Deng is an integrative medicine specialist who strives to inspire and empower people with cancer to make themselves strong in body, mind, and spirit. Dr. Deng incorporates some Eastern medicine approaches that are supported by scientific evidence and focus on nutrition, physical activity, stress management, sleep, and circadian rhythms. He also advises patients on the proper use of herbs and dietary supplements so that they may experience potential benefits while avoiding harm.

As the leader of Memorial Sloan Kettering Cancer Center’s Integrative Medicine Clinical Program, Dr. Deng works closely with a team of highly professional therapists who provide acupuncture, massage therapy, mind-body therapies, yoga, qigong, exercise regimens, and music therapy — all tailored to the needs of cancer patients and survivors.

He is also the principal investigator of several research projects on acupuncture, yoga, and botanical/herbal agents; supervises MSK’s Integrative Medicine Physician Education Program; and writes clinical practice guidelines and textbook chapters. Dr. Deng actively participates in the integrative medicine community by giving lectures internationally to professional and lay audiences, and by reviewing protocols, manuscripts, and grant applications in his field of expertise. He is a past president of the Society for Integrative Oncology.

Clinical Professor, Supportive Care Medicine and Medical Oncology and Director of Integrative Medicine

City of Hope National Medical Center

Richard T. Lee, MD is a Clinical Professor in the Departments of Supportive Care Medicine and Medical Oncology at City of Hope National Medical Center. Dr. Lee serves as Director of Integrative Medicine for the entire enterprise. In this role, he oversees the clinical, research and educational programs related to integrative oncology. As a medical oncologist, he provides routine oncologic care with a focus on gastrointestinal cancers.  Additionally, he provides broad consultative services regarding supportive and integrative cancer approaches.

From 2009 until 2015, Dr. Lee served as the Director for the Integrative Medicine Center at MD Anderson Cancer Center in Houston, TX. There he led the transformation of the clinical program into an evidence-based clinical service and helped establish an inpatient integrative consultation service – one of the first in the nation. Prior to City of Hope, he was the inaugural chair of the Helen Moss Foundation-Schoff Family Professor of Integrative Oncology at Case Western Reserve University School of Medicine. He served as Director of Supportive and Integrative Oncology at the University Hospitals Seidman Cancer Center, and as Director of the Case Center for Integrative Oncology from 2016-2021. He has been an active member of the Society for Integrative Oncology and the American Society for Clinical Oncology. His work has led to over 70 publications including in peer reviewed cancer journals and book chapters and has been an invited speaker to both national and international meetings.

Currently, Dr. Lee is currently building integrative oncology services at the City of Hope – Orange County Lennar Foundation Cancer Center with plans for expansion to the entire enterprise. His research includes health services research utilizing survey studies exploring both patients’ and clinicians’ perspectives about supportive and integrative services. He also has been exploring the anticancer activities of natural plants, specifically mistletoe and mushrooms, in order to develop new cancer treatments. Dr. Lee has ongoing clinical research evaluating the benefits of acupuncture and meditation

Dr. Dugald Seely is a naturopathic doctor and clinician scientist whose focus is on the application and evaluation of integrative oncology. Embodying a synthesis of evidence based complementary medicine with conventional medicine, integrative oncology offers a path for improved clinical care that is obvious to the conscientious practitioner and that best supports patients in the way they most need. Dr. Seely seeks to build a richer integration of this medicine within the health care system as a respected path for practitioners and researchers and ultimately for patients to be best served.

Dr. Seely is the founder and executive director of the Ottawa Integrative Cancer Centre (OICC) and executive director for the department of research & clinical epidemiology at the Canadian College of Naturopathic Medicine. Dr. Seely is an affiliate investigator at the Ottawa Hospital Research Institute; Adjunct Professor with the Faculty of Medicine at the University of Ottawa; Integrative Oncology Section Editor for the journal Current Oncology; and Vice President of the Oncology Association of Naturopathic Physicians. In research, Dr. Seely has led numerous clinical studies and synthesis reviews having published over 70 peer-reviewed papers. Seely is a frequent speaker and is actively engaged in the research community through a number of associations. In clinic, Dr. Seely sees patients three days a week at the OICC and is thrilled to be able to combine his passion for research and in the service of the patients he cares for.

Cross-Appointed Member, Professor

University of Ottawa

Dr. Matar’s expertise is focused on research related to nutrition/immunology/cancer and establishing the role of prebiotics and probiotics on mucosal and tumoral immunity. Dr. Matar is a pioneer in demonstrating the protective effects of probiotics within the Gut-Breast Axis. Additionally, her work on nutritional programming has led to a greater understanding of the mechanisms underlining the immunoprotective role of probiotics in modulating TLRs, cancer stem cells, and microRNAs. In collaboration with International Agency for Research on Cancer, a specialized agency of the World Health Organization, she is working toward development of microbiome-based health applications for chemoprevention of breast cancer.

Dr. Matar is the recipient of numerous awards, most recently including the Research Impact Faculty’s Award (2021), the Union for International Cancer Control UICC Technical Fellowship (2020), an Academic Member of the International Life Sciences Institute (ILSI) North America Advisory Committee (2016-2018), and Japan’s Best Research Award (2016) in recognition of an outstanding contribution to research in nutrition and integrative medicine.